NeoGenomics, Inc. Other Significant Noncash Transaction, Value of Consideration Given
NeoGenomics, Inc. (NEO) reported Other Significant Noncash Transaction, Value of Consideration Given of $29.17 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2021-11-04
- NeoGenomics, Inc. other significant noncash transaction, value of consideration given for the quarter ending 2021-09-30 was $0.00.
- NeoGenomics, Inc. other significant noncash transaction, value of consideration given for the quarter ending 2020-09-30 was $0.00.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $29.17M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $29.17M 10-Q · filed 2021-08-09 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |